THBS1 and CD47 also jointly participate in anti-tumor immunosuppressive effects [67], where upregulated expression of THBS1-CD47 not only accelerates the progression of EMT, but also induces fibrosis and inflammation [68]. Here, CD47 is linked to neoplasm.